Expression of EAAT1 reflects a possible neuroprotective function of reactive astrocytes and activated microglia following human traumatic brain injury

Histology and Histopathology

Volumn 22, Issue 4-6, 2007, Pages 515-526

  Beschorner, Rudi ^a   Dietz, K ^a   Schauer, N ^a   Mittelbronn, M ^a   Schluesener, H J ^a   Trautmann, K ^a   Meyermann, R ^a   Simon, P ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Excitatory amino acid transporters; Microglial activation; Neuroprotection; Traumatic brain injury

Indexed keywords

EXCITATORY AMINO ACID TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; GLUTAMATE TRANSPORTER; SLC1A2 PROTEIN, HUMAN; SLC1A3 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTE; BRAIN CORTEX; CELL ACTIVATION; CELL FUNCTION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MACROPHAGE; MALE; MICROGLIA; NEUROPROTECTION; PARENCHYMA; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TRAUMATIC BRAIN INJURY; WHITE MATTER; BRAIN; BRAIN INJURY; CASE CONTROL STUDY; METABOLISM; MIDDLE AGED; PATHOLOGY; TIME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASTROCYTES; BRAIN; BRAIN INJURIES; CASE-CONTROL STUDIES; EXCITATORY AMINO ACID TRANSPORTER 1; FEMALE; GLUTAMATE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; MIDDLE AGED; TIME FACTORS;

EID: 34247544369     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (76)

1. Anderson K.J. (1991). Increased density of excitatory amino acid transport sites in the hippocampal formation following an entorhinal lesion. Brain Res. 562, 285-290.
2. Arvidsson A., Kokaia Z. and Lindvall O. (2001). N-methyl-D-aspartate receptor-mediated increase of neurogenesis in adult rat dentate gyrus following stroke. Eur. J. Neurosci. 14, 10-18.
3. Baker A.J., Moulton R.J., MacMillan V.H. and Shedden P.M. (1993). Excitatory amino acids in cerebrospinal fluid following traumatic brain injury in humans. J. Neurosurg. 79, 369-372.
4. Banner S.J., Fray A.E., Ince P.G., Steward M., Cookson M.R. and Shaw P.J. (2002). The expression of the glutamate re-uptake transporter excitatory amino acid transporter 1 (EAAT1) in the normal human CNS and in motor neurone disease: an immunohistochemical study. Neuroscience 109, 27-44.
5. Baskaya M.K., Dogan A., Rao A.M. and Dempsey R.J. (2000). Neuroprotective effects of citicoline on brain edema and blood-brain barrier breakdown after traumatic brain injury. J. Neurosurg. 92, 448-452.
6. Benveniste H., Drejer J., Schousboe A. and Diemer N.H. (1984). Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43, 1369-1374.
7. Beschorner R., Nguyen T.D., Gozalan F., Pedal I., Mattern R., Schluesener H.J., Meyermann R. and Schwab J.M. (2002). CD14 expression by activated parenchymal microglia/macrophages and infiltrating monocytes following human traumatic brain injury. Acta Neuropathol. (Berl) 103, 541-549.
8. Bonde C., Sarup A., Schousboe A., Gegelashvili G., Zimmer J. and Noraberg J, (2003). Neurotoxic and neuroprotective effects of the glutamate transporter inhibitor DL-threo-beta-benzyloxyaspartate (DL-TBOA) during physiological and ischemia-like conditions. Neurochem. Int. 43, 371-380.
9. Bondoli A., Barbi S., Camaioni D., Della-Morte F. and Magalini S.I. (1981). Plasma and cerebrospinal fluid free amino acid concentration in post-traumatic cerebral oedema in patients with shock. Resuscitation 9, 119-124.
10. Cakir E., Usul H., Peksoylu B., Sayin O.C., Alver A., Topbas M., Baykal S. and Kuzeyli K. (2005). Effects of citicoline on experimental spinal cord injury. J. Clin. Neurosci. 12, 924-927.
11. Castillo J., Davalos A., Naveiro J. and Noya M. (1996). Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke. Stroke 27, 1060-1065.
12. Chen W.H. and Tzeng S.F. (2005). Pituitary adenylate cyclase-activating polypeptide prevents cell death in the spinal cord with traumatic injury. Neurosci. Lett. 384, 117-121.
13. Choi D.W. and Rothman S.M. (1990). The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu. Rev. Neurosci. 13, 171-182.
14. Chretien F., Vallat-Decouvelaere A.V., Bossuet C., Rimaniol A.C., Le Grand R., Le Pavec G., Creminon C., Dormont D., Gray F. and Gras G. (2002). Expression of excitatory amino acid transporter-2 (EAAT-2) and glutamine synthetase (GS) in brain macrophages and microglia of SIVmac251-infected macaques. Neuropathol. Appl. Neurobiol. 28, 410-417.
15. Chretien F., Le Pavec G., Vallat-Decouvelaere A.V., Delisle M.B., Uro-Coste E., Ironside J.W., Gambetti P., Parchi P., Creminon C., Dormont D., Mikol J., Gray F. and Gras G. (2004). Expression of excitatory amino acid transporter-1 (EAAT-1) in brain macrophages and microglia of patients with prion diseases. J. Neuropathol. Exp. Neurol. 63, 1058-1071.
16. Clausen F., Lundqvist H., Ekmark S., Lewen A., Ebendal T. and Hillered L. (2004). Oxygen free radical-dependent activation of extracellular signal-regulated kinase mediates apoptosis-like cell death after traumatic brain injury. J. Neurotrauma 21, 1168-1182.
17. De Keyser J., Sulter G. and Luiten P.G. (1999). Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing? Trends Neurosci. 22, 535-540.
18. Dirnagl U., ladecola C. and Moskowitz M.A. (1999). Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22, 391-397.
19. Duan S., Anderson C.M., Stein B.A. and Swanson R.A. (1999). Glutamate induces rapid upregulation of astrocyte glutamate transport and cell-surface expression of GLAST. J. Neurosci. 19, 10193-10200.
20. Eisenstein M. (2005). New career possibilities for certain antibiotics? Lab. Anim. 34, 10.
21. Farkas O., Tamas A., Zsombok A., Reglodi D., Pal J., Buki A., Lengvari I., Povlishock J.T. and Doczi T. (2004). Effects of pituitary adenylate cyclase activating polypeptide in a rat model of traumatic brain injury. Regul. Pept. 123, 69-75.
22. Fournier K.M., Gonzalez M.I. and Robinson M.B. (2004). Rapid trafficking of the neuronal glutamate transporter, EAACI: evidence for distinct trafficking pathways differentially regulated by protein kinase C and platelet-derived growth factor. J. Biol. Chem. 279, 34505-34513.
23. Fukamachi S., Furuta A., Ikeda T., Ikenoue T., Kaneoka T., Rothstein J.D. and Iwaki T. (2001). Altered expressions of glutamate transporter subtypes in rat model of neonatal cerebral hypoxia-ischemia. Brain Res. Dev. Brain Res. 132, 131-139.
24. Ginsberg S.D. (1996). Fimbria-fornix transections selectively down-regulate subtypes of glutamate transporter and glutamate receptor proteins in septum and hippocampus. J. Neurochem. 67, 1208-1216.
25. Graham D.I., Genarelli T.A. and McIntosh T.K. (2002) Trauma. In: Greenfield's Neuropathology. 7th ed. Graham D.I. and Lantos P.L. (eds). Arnold. London. pp 823-898.
26. Gras G., Chretien F., Vallat-Decouvelaere A.V., Le Pavec G., Pomheray F., Bossuet C., Leone C., Mialocq P., Dereuddre-Bosquet N., Clayette P., Le Grand R., Creminon C., Dormont D., Rimaniol A.C. and Gray F. (2003). Regulated expression of sodium-dependent glutamate transporters and synthetase: a neuroprotective mie for activated microglia and macrophages in HIV infection? Brain Pathol. 13, 211-222.
27. Hoyte L., Barber P.A., Buchan A.M. and Hill M.D. (2004). The rise and fall of NMDA antagonists for ischemic stroke. Curr. Mol. Med. 4, 131-136.
28. Hurtado O., Moro M.A., Cardenas A., Sanchez V., Fernandez-Tome P., Leza J.C., Lorenzo P., Secades J.J., Lozano R., Davalos A., Castillo J. and Lizasoain I. (2005). Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport. Neurobiol. Dis. 18, 336-345.
29. Ikematsu K., Tsuda R., Kondo T. and Nakasono I. (2002). The expression of excitatory amino acid transporter 2 in traumatic brain injury. Forensic Sci. Int. 130, 83-89.
30. Ikematsu K., Tsuda R., Orihara Y. and Nakasono I. (2001). The expression of excitatory amino acid transporter 2 (EAAT2) in forensic autopsy cases. Forensic Sci. Int. 118, 49-55.
31. Ikonomidou C. and Turski L. (2002). Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol. 1, 383-386.
32. Ikonomidou C., Stefovska V. and Turski L. (2000). Neuronal death enhanced by N-methyl-D-aspartate antagonists. Proc. Natl. Acad. Sci. USA 97, 12885-12890.
33. Kanner B.I. and Sharon I. (1978). Active transport of L-glutamate by membrane vesicles isolated from rat brain. Biochemistry 17, 3949-3953.
34. Kaya S.S., Mahmood A., Li Y., Yavuz E., Goksel M. and Chopp M. (1999). Apoptosis and expression of p53 response proteins and cyclin D1 after cotrical impact in rat brain. Brain. Res. 818, 23-33.
35. Knecht K., Michalak A., Rose C., Rothstein J.D. and Butterworth R.F. (1997). Decreased glutamate transporter (GLT-1) expression in frontal cortex of rats with acute liver failure. Neurosci. Lett. 229, 201-203.
36. Krum J.M., Phillips T.M. and Rosenstein J.M. (2002). Changes in astroglial GLT-1 expression after neural transplantation or stab wounds. Exp. Neurol. 174, 137-149.
37. Lopez-Bayghen E. and Ortega A. (2004). Glutamate-dependent transcriptional regulation of GLAST: role of PKC. J. Neurochem. 91, 200-209.
38. Lopez-Redondo F., Nakajima K., Honda S., Kohsaka S. (2000). Glutamate transporter GLT-1 is highly expressed in activated microglia following facial nerve axotomy. Brain Res. Mol. Brain Res. 76, 429-435.
39. Matsuura S., Ikegaya Y., Yamada M.K., Nishiyama N. and Matsuki N. (2002). Endothelin downregulates the glutamate transporter GLAST in cAMP-differentiated astrocytes in vitro. Glia 37, 178-182.
40. Mitani A. and Tanaka K. (2003). Functional changes of glial glutamate transporter GLT-1 during ischemia: an in vivo study in the hippocampal CA1 of normal mice and mutant mice lacking GLT-1. J. Neurosci. 23, 7176-7182.
41. Mittelbronn M., Dietz K., Schluesener H.J. and Meyermann R. (2001). Local distribution of microglia in the normal adult human central nervous system differs by up to one order of magnitude. Acta Neuropathol. 101, 249-255.
42. Mori T., Tateishi N., Kagamiishi Y., Shimoda T., Satoh S., Ono S., Katsube N. and Asano T. (2004). Attenuation of a delayed increase in the extracellular glutamate level in the peri-infarct area following focal cerebral ischemia by a novel agent ONO-2506. Neurochem. Int. 45, 381-387.
43. Muir K.W. and Lees K.R. (2003). Excitatory amino acid antagonists for acute stroke. Cochrane Database Syst. Rev. CD001244.
44. Nakajima K., Tohyama Y., Kohsaka S. and Kurihara T. (2001). Ability of rat microglia to uptake extracellular glutamate. Neurosci. Lett. 307, 171-174.
45. Namura S., Maeno H., Takami S., Jiang X.F., Kamichi S., Wada K. and Nagata I. (2002). Inhibition of glial glutamate transporter GLT-1 augments brain edema after transient focal cerebral ischemia in mice. Neurosci. Lett. 324, 117-120.
46. Niederberger E., Schmidtko A., Rothstein J.D., Geisslinger G. and Tegeder I. (2003). Modulation of spinal nociceptive processing through the glutamate transporter GLT-1. Neuroscience 116, 81-87.
47. Palacin M., Estevez R., Bertran J. and Zorzano A. (1998). Molecular biology of mammalian plasma membrane amino acid transporters. Physiol. Rev. 78, 969-1054.
48. Pawlak J., Brito V., Kuppers E. and Beyer C. (2005). Regulation of glutamate transporter GLAST and GLT-1 expression in astrocytes by estrogen. Brain Res. Mol. Brain Res. 138, 1-7.
49. Persson L. and Hillered L. (1992). Chemical monitoring of neurosurgical intensive care patients using intracerebral microdialysis. J. Neurosurg. 76, 72-80.
50. Persson M., Brantefjord M., Hansson E. and Ronnback L. (2005). Lipopolysaccharide increases microglial GLT-1 expression and glutamate uptake capacity in vitro by a mechanism dependent on TNF-alpha. Glia 51, 111-120.
51. Phillis J.W., Ren J. and O'Regan M.H. (2000). Transporter reversal as a mechanism of glutamate release from the ischemic rat cerebral cortex: studies with DL-threo-beta-benzyloxyaspartate. Brain Res. 868, 105-112.
52. Rao V.L., Baskaya M.K., Dogan A., Rothstein J.D. and Dempsey R.J. (1998). Traumatic brain injury down-regulates glial glutamate transporter (GLT-1 and GLAST) proteins in rat brain. J. Neurochem. 70, 2020-2027.
53. Rao V.L., Bowen K.K. and Dempsey R.J. (2001). Transient focal cerebral ischemia down-regulates glutamate transporters GLT-1 and EAAC1 expression in rat brain. Neurochem. Res. 26, 497-502.
54. Rimaniol A.C., Haik S., Martin M., Le Grand R., Boussin F.D., Dereuddre-Bosquet N., Gras G. and Dormont D. (2000). Na+-dependent high-affinity glutamate transport in macrophages. J. Immunol. 164, 5430-5438.
55. Robelet S., Melon C., Guillet B., Salin P. and Kerkerian-Le-Goff L. (2004). Chronic L-DOPA treatment increases extracellular glutamate levels and GLT1 expression in the basal ganglia in a rat model of Parkinson's disease. Eur. J. Neurosci. 20, 1255-1266.
56. Robinson M.B. (1999). The family of sodium-dependent glutamate transporters: a focus on the GLT-1/EAAT2 subtype. Neurochem. Int. 33, 479-491.
57. Rossi D.J., Oshima T. and Attwell D. (2000). Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature 403, 316-321.
58. Rothstein J.D., Dykes-Hoberg M., Pardo C.A., Bristol L.A., Jin L., Kuncl R.W., Kanai Y., Hediger M.A., Wang Y., Schielke J.P. and Welty D.F. (1996). Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16, 675-686.
59. Rothstein J.D., Jin L., Dykes-Hoberg M. and Kuncl R.W. (1993). Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc. Natl. Acad. Sci. USA 90, 6591-6595.
60. Rothstein J.D., Patel S., Regan M.R., Haenggeli C., Huang Y.H., Bergles D.E., Jin L., Dykes-Hoberg M., Vidensky S., Chung D.S., Toan S.V., Bruijn L.I., Su Z.Z., Gupta P. and Fisher P.B. (2005). Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433, 73-77.
61. Rozyczka J., Figiel M. and Engele J. (2004). Endothelins negatively regulate glial glutamate transporter expression. Brain Pathol. 14, 406-414.
62. Shimada F., Shiga Y., Morikawa M., Kawazura H., Morikawa O., Matsuoka T., Nishizaki T. and Saito N. (1999). The neuroprotective agent MS-153 stimulates glutamate uptake. Eur. J. Pharmacol. 386, 263-270.
63. Simantov R., Crispino M., Hoe W., Broutman G., Tocco G., Rothstein J.D. and Baudry M. (1999a). Changes in expression of neuronal and glial glutamate transporters in rat hippocampus following kainate-induced seizure activity. Brain Res. Mol. Brain Res. 65, 112-123.
64. Simantov R., Liu W., Broutman G. and Baudry M. (1999b). Antisense knockdown of glutamate transporters alters the subfield selectivity of kainate-induced cell death in rat hippocampal slice cultures. J. Neurochem. 73, 1828-1835.
65. Swanson R.A., Liu J., Miller J.W., Rothstein J.D., Farrell K., Stein B.A. and Longuemare M.C. (1997). Neuronal regulation of glutamate transporter subtype expression in astrocytes. J. Neurosci. 17, 932-940.
66. Tanaka K., Watase K., Manabe T., Yamada K., Watanabe M., Takahashi K., Iwama H., Nishikawa T., Ichihara N., Kikuchi T., Okuyama S., Kawashima N., Hori S., Takimoto M. and Wada K. (1997). Epilepsy and exacerbation of brain injury in mice lacking the glutamate transpoder GLT-1. Science 276, 1699-1702.
67. Torp R., Lekieffre D., Levy L.M., Haug F.M., Danbolt N.C., Meldrum B.S. and Ottersen O.P. (1995). Reduced postischemic expression of a glial glutamate transporter, GLT1, in the rat hippocampus. Exp. Brain. Res. 103, 51-58.
68. Umemura K., Gemba T., Mizuno A. and Nakashima M. (1996). Inhibitory effect of MS-153 on elevated brain glutamate level induced by rat middle cerebral artery occlusion. Stroke 27, 1624-1628.
69. Vallat-Decouvelaere A.V., Chretien F., Gras G., Le Pavec G., Dormont D. and Gray F. (2003). Expression of excitatory amino acid transporter-1 in brain macrophages and microglia of HIV-infected patients. A neuroprotective role for activated microglia? J. Neuropathol. Exp. Neurol. 62, 475-485.
70. van Landeghem F.K., Stover J.F., Bechmann I., Bruck W., Unterberg A., Buhrer C. and von Deimling A. (2001). Early expression of glutamate transporter proteins in ramified microglia after controlled cortical impact injury in the rat. Glia 35, 167-179.
71. Vera-Portocarrero L.P., Mills C.D., Ye Z., Fullwood S.D., McAdoo D.J., Hulsebosch C.E. and Westlund K.N. (2002). Rapid changes in expression of glutamate transporters after spinal cord injury. Brain Res. 927, 104-110.
72. Voutsinos-Porche B., Knott G., Tanaka K., Quairiaux C., Welker E. and Bonvento G. (2003). Glial glutamate transporters and maturation of the mouse somatosensory cortex. Cereb. Cortex 13, 1110-1121.
73. Wadiche J.I., Arriza J.L., Amara S.G. and Kavanaugh M.P. (1995). Kinetics of a human glutamate transporter. Neuron 14, 1019-1027.
74. Wang C.X. and Shuaib A. (2005). NMDNNR2B selective antagonists in the treatment of ischemic brain injury. Curr. Drug Targets. CNS. Neurol. Disord. 4, 143-151.
75. Werner P., Pitt D. and Raine C.S. (2001). Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann. Neurol. 50, 169-180.
76. Williams S.M., Sullivan R.K., Scott H.L., Finkelstein D.I., Colditz P.B., Lingwood B.E., Dodd P.R. and Pow D.V. (2005). Glial glutamate transporter expression patterns in brains from multiple mammalian species. Glia 49, 520-541.